JP2024513392A5 - - Google Patents
Info
- Publication number
- JP2024513392A5 JP2024513392A5 JP2023560497A JP2023560497A JP2024513392A5 JP 2024513392 A5 JP2024513392 A5 JP 2024513392A5 JP 2023560497 A JP2023560497 A JP 2023560497A JP 2023560497 A JP2023560497 A JP 2023560497A JP 2024513392 A5 JP2024513392 A5 JP 2024513392A5
- Authority
- JP
- Japan
- Prior art keywords
- lys
- cys
- substituted
- 1peg2
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026038265A JP2026088199A (ja) | 2021-04-01 | 2026-03-10 | コンジュゲートされたヘプシジン模倣物 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169538P | 2021-04-01 | 2021-04-01 | |
| US202163169527P | 2021-04-01 | 2021-04-01 | |
| US202163169533P | 2021-04-01 | 2021-04-01 | |
| US63/169,538 | 2021-04-01 | ||
| US63/169,527 | 2021-04-01 | ||
| US63/169,533 | 2021-04-01 | ||
| US202263325323P | 2022-03-30 | 2022-03-30 | |
| US63/325,323 | 2022-03-30 | ||
| PCT/US2022/022809 WO2022212696A1 (en) | 2021-04-01 | 2022-03-31 | Conjugated hepcidin mimetics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026038265A Division JP2026088199A (ja) | 2021-04-01 | 2026-03-10 | コンジュゲートされたヘプシジン模倣物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513392A JP2024513392A (ja) | 2024-03-25 |
| JP2024513392A5 true JP2024513392A5 (cg-RX-API-DMAC7.html) | 2025-03-06 |
Family
ID=83456776
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560497A Pending JP2024513392A (ja) | 2021-04-01 | 2022-03-31 | コンジュゲートされたヘプシジン模倣物 |
| JP2026038265A Pending JP2026088199A (ja) | 2021-04-01 | 2026-03-10 | コンジュゲートされたヘプシジン模倣物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026038265A Pending JP2026088199A (ja) | 2021-04-01 | 2026-03-10 | コンジュゲートされたヘプシジン模倣物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250277012A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4314017A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024513392A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022249095A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3213688A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202304951A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022212696A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| CA2949215C (en) | 2014-05-16 | 2023-03-14 | Protagonist Therapeutics, Inc. | .alpha.4.beta.7 integrin thioether peptide antagonists |
| SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| WO2018022937A1 (en) | 2016-07-27 | 2018-02-01 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| WO2019157268A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| MX2022008740A (es) | 2020-01-15 | 2022-09-23 | Janssen Biotech Inc | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. |
| SMT202500254T1 (it) | 2020-01-15 | 2025-09-12 | Janssen Biotech Inc | Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| KR20240034224A (ko) | 2021-07-14 | 2024-03-13 | 얀센 바이오테크 인코포레이티드 | 인터류킨-23 수용체의 지질화된 펩티드 억제제 |
| US20250170216A1 (en) * | 2022-02-02 | 2025-05-29 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| EP4472995A4 (en) * | 2022-02-02 | 2025-11-19 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002079235A2 (en) * | 2001-03-30 | 2002-10-10 | University Of Copenhagen | Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease |
| EP4091624A1 (en) * | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| AU2015279571A1 (en) * | 2014-06-27 | 2017-02-02 | Protagonist Therapeutics, Inc. | Hepcidin and mini-hepcidin analogues and uses therof |
| CA3009834A1 (en) * | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2018128828A1 (en) * | 2016-12-23 | 2018-07-12 | Bayer Healthcare Llc | Novel hepcidin mimetics and uses thereof |
| WO2019157268A1 (en) * | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| US20220372099A1 (en) * | 2019-09-03 | 2022-11-24 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| IL299530A (en) * | 2020-07-28 | 2023-02-01 | Protagonist Therapeutics Inc | Psidine is a conjugated mimetic |
-
2022
- 2022-03-31 WO PCT/US2022/022809 patent/WO2022212696A1/en not_active Ceased
- 2022-03-31 AU AU2022249095A patent/AU2022249095A1/en active Pending
- 2022-03-31 US US18/284,835 patent/US20250277012A1/en active Pending
- 2022-03-31 EP EP22782206.1A patent/EP4314017A4/en active Pending
- 2022-03-31 JP JP2023560497A patent/JP2024513392A/ja active Pending
- 2022-03-31 CA CA3213688A patent/CA3213688A1/en active Pending
- 2022-04-01 TW TW111112892A patent/TW202304951A/zh unknown
-
2026
- 2026-03-10 JP JP2026038265A patent/JP2026088199A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024513391A5 (cg-RX-API-DMAC7.html) | ||
| JP2023540679A5 (cg-RX-API-DMAC7.html) | ||
| JP2023536463A5 (cg-RX-API-DMAC7.html) | ||
| US12234300B2 (en) | Conjugated hepcidin mimetics | |
| US10278957B2 (en) | Opioid agonist peptides and uses thereof | |
| ES3058577T3 (en) | Conjugated hepcidin mimetics for use in treating of polycythemia vera | |
| CN105451755B (zh) | 铁调素类似物和其用途 | |
| ES2890600T3 (es) | Péptidos de tioéter antagonistas de integrina alfa4beta7 | |
| CA3189432A1 (en) | Conjugated hepcidin mimetics | |
| US20240293511A1 (en) | Hepcidin mimetics for treatment of hereditary hemochromatosis | |
| JP7849383B2 (ja) | コンジュゲートされたヘプシジン模倣物 | |
| JP2012530145A5 (cg-RX-API-DMAC7.html) | ||
| WO2017117411A1 (en) | Analogues of hepcidin mimetics with improved in vivo half lives | |
| WO2022212696A1 (en) | Conjugated hepcidin mimetics | |
| JP2015533833A5 (cg-RX-API-DMAC7.html) | ||
| US20240226225A1 (en) | Conjugated hepcidin mimetics | |
| KR100360975B1 (ko) | 위장운동자극활성을가지는폴리펩티드 | |
| SK150196A3 (en) | Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use | |
| CN117480176A (zh) | 用于治疗遗传性血色病的铁调素模拟物 | |
| EA053112B1 (ru) | Конъюгированные миметики гепсидина | |
| CN117730089A (zh) | 结合型铁调素模拟物 | |
| JPS62111997A (ja) | ポリペプチド | |
| NZ751741B2 (en) | Hepcidin analogues and uses therof |